scorecardresearch
Tuesday, Nov 29, 2022
Premium

Covid-19 vaccine tracker, Sept 30: Why Elon Musk won’t take a coronavirus vaccine

Coronavirus (COVID-19) vaccine update, September 30: Elon Musk has said he and his family would not take a coronavirus vaccine even if it became immediately available. "I am not at risk, neither are my kids," he said.

elon musk coronavirus vaccine, coronavirus news, coronavirus vaccine, covid vaccine news, covid 19 vaccine indiaElon Musk, chief executive officer of Space Exploration Technologies Corp. (SpaceX) and Tesla Inc. (Bloomberg Photo: Bronte Wittpenn)

Coronavirus vaccine tracker: One of the richest persons in the world, and the man behind celebrated innovative enterprises like Tesla and SpaceX, Elon Musk has said he and his family would not take a coronavirus vaccine even if it became immediately available.

“I am not at risk, neither are my kids,” Musk said in The New York Times podcast ‘Sway’.

Musk has long been critical of lockdown-kind of responses to the epidemic, suggesting these were over-reactions.

He said work at SpaceX had not been interrupted even for a day during the pandemic. “We had national security clearance because we were doing national security work. We sent astronauts to the space station and back,” he said.

Subscriber Only Stories
UPSC Key- November 28, 2022: Why you should read ‘China’s Zero-Covid poli...Premium
Delhi reports another gruesome case of body-chopping and murderous aggres...Premium
UPSC Essentials | Key terms of the past week with MCQsPremium
ExplainSpeaking | A profile of Gujarat’s economy before electionsPremium

📣 Express Explained is now on Telegram. Click here to join our channel (@ieexplained) and stay updated with the latest

World Bank plans $12 billion vaccine financing for poor and developing countries

World Bank has said it was hoping to come up with a $12 billion financing plan to help poorer and developing countries to access coronavirus vaccines when they become available, Reuters has reported.

“Our goal is to alter the course of the pandemic for the low and middle income developing countries. This is a market signal to the manufacturers that there will be financing available for the developing countries and there will be demand,” World Bank president David Malpass said an interview with Reuters.

Advertisement

Some countries like the United States and the UK have spent billions of dollars to pre-book supplies of multiple coronavirus vaccines that are under development right now. However, a WHO-led initiative to ensure that everyone gets equitable access to the vaccine when it becomes available is struggling to take off in the absence of adequate funds.

Hunt for coronavirus vaccine: The story so far

  • 191 vaccine candidates in pre-clinical or clinical trials
  • 40 of them in clinical trials
  • Ten in final stages, phase-III of human trials
  • At least eight candidate vaccines being developed in India. Two of these have entered phase -II trials after completing phase-I.

The ones most talked about:

* AstraZeneca/Oxford University
* Moderna
* Pfizer/BioNTech
* Johnson & Johnson
* Sanofi/GlaxoSmithKline
* Novavax
* Russian vaccine, developed by Gamaleya Insttiute in Moscow
* Three Chinese vaccines that have been approved for use in China without phase-3 trials being completed. One of them has been given emergency use authorisation in UAE

Advertisement

(As on September 28; source: WHO Coronavirus vaccine landscape of September 28, 2020)

First published on: 30-09-2020 at 10:08:55 am
Next Story

COVID-19 cases rising among US children as schools reopen

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement
close